•
Dec 31, 2022

Elevance Health Q4 2022 Earnings Report

Elevance Health reported strong financial results for Q4 2022, marked by double-digit growth in revenue, operating earnings and adjusted earnings per share.

Key Takeaways

Elevance Health reported Q4 2022 results with $39.7 billion in operating revenue and adjusted EPS of $5.23. The company's medical membership reached 47.5 million, driven by growth in both Government and Commercial & Specialty Business segments.

GAAP net income was $3.93 per share in the fourth quarter, and adjusted net income was $5.23 per share.

Medical membership totaled approximately 47.5 million as of December 31, 2022, an increase of 2.2 million year-over-year.

Operating revenue was $39.7 billion in the fourth quarter of 2022, an increase of 10.1 percent year-over-year.

The benefit expense ratio was 89.4 percent in the fourth quarter of 2022, a decrease of 10 basis points year-over-year.

Total Revenue
$39.7B
Previous year: $36B
+10.1%
EPS
$5.23
Previous year: $5.14
+1.8%
Total Medical Membership
47.53M
Previous year: 45.4M
+4.7%
Gross Profit
$36.3B
Previous year: $9.04B
+301.2%
Cash and Equivalents
$7.39B
Previous year: $4.88B
+51.4%
Free Cash Flow
-$1.82B
Previous year: $1.33B
-236.3%
Total Assets
$103B
Previous year: $97.5B
+5.4%

Elevance Health

Elevance Health

Elevance Health Revenue by Segment

Forward Guidance

The Company expects GAAP net income to be greater than $29.80 per share in 2023, and adjusted net income to be greater than $32.60 per share.